Nymi biometric wearables bring continuous authentication to Xyntek enterprise platform
Nymi’s biometric fingerprint and ECG liveness for continuous authentication join a number of iris and fingerprint scanning technologies integrated with Xyntek’s platform. The continuous authentication capabilities of Nymi make it suitable for controlled laboratory, manufacturing, and healthcare processes by facilitating rapid logins and e-signatures with a tap of the wrist, according to the announcement.
“In the past, a user’s identity was verified based on what we know, such as our username, passwords, and PINs, or what we have, such as ID and access cards,” says Mac Hashemian, P.E., CEO of Xyntek. “Biometric authentication enables user identification based on who we are by using unique physical characteristics like iris patterns and fingerprints to allow access to extremely sensitive systems, information and/or environments. With digital transformation and the push for mobility, we now have to factor in ‘what extends us’ to this equation. The Nymi Biometric wearable technology offers an additional level of flexibility that provides operators with a more efficient way to achieve compliance and security without compromising productivity.”
Xyntek provides a high-availability centralized authentication service for using biometrics as enterprise credentials, and the company says it supports all standard biometric devices.
“There are many use cases in the Life Sciences GxP environments that can benefit from wearable authentication devices,” comments Nymi Vice President Andrew Foxcroft. “By combining our technology with Xyntek’s Biometric Authentication Platform, we can address a number of important use cases featuring enterprise authentication that delivers data integrity and security, allowing highly regulated industries to achieve compliance and productivity.”
The partnership comes just a month after a similar deal with pharmaceutical manufacturing supplier POMS.